Welcome : Guest

Akebia Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Akebia Therapeutics, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 82 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63674
Price: $3500
Company Type: Public
Pages: 84
Date: November 2016
Market Data Tables: 82

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Kidney Disease Drugs......3
Table 1: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......3
Table 2: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......4
Table 3: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......5
Table 4: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......6
Table 5: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......7
Table 6: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......8
Table 7: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......9
Dialysis......10
Table 8: Dialysis Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Dialysis Care, Dialysis Products......10
Table 9: No. of Dialysis Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, Peritoneal Dialysis Patients, and Transplant patients......11
Table 10: No. of Dialysis Patients by Geographic Region Worldwide (2015) - Percentage Share Breakdown for Europe, Japan, Rest of World (RoW), and USA......12
Table 11: Dialysis Product Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemodialysis Products, and Peritoneal Dialysis Products......13
Table 12: No. of Dialysis Patients by Category in China (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, and Peritoneal Dialysis Patients......14
Dialysis Patients......15
Table 13: No. of Dialysis Patients by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume for Asia-Pacific, Europe, the Middle East and Africa (EMEA), Latin America, and North America......15
Table 14: No. of Dialysis Patients by Treatment Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Hemodialysis, and Peritoneal Dialysis......16
End-Stage Renal Disease (ESRD)......17
Table 15: End-Stage Renal Disease (ESRD) Market by Cause in China (2015) - Percentage Share Breakdown by Value for Diabetic Nephropathy, Glomerular Disease, Hypertension Caused Renal Disease and Others......17
Table 16: End-Stage Renal Disease (ESRD) Cases by Age Group in the US (2015) - Percentage Share Breakdown for 45-64, 65-74, 75+, and Others......18
Table 17: End-Stage Renal Disease (ESRD) Cases by Diagnosis in the US (2015) - Percentage Share Breakdown by Value for Cystic Kidney, Diabetes, Glomerulonephritis, Hypertension, and Others......19
Cancer Drugs......20
Table 18: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......20
Table 19: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......21
Cancer Market......22
Table 20: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......22
Table 21: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......23
Table 22: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......24
Table 23: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......25
Table 24: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......26
Table 25: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......27
Table 26: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......28
Table 27: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......29
Cancer Patients......30
Table 28: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......30
Table 29: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......31
Table 30: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......32
Table 31: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......33
Table 32: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......34
Table 33: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......35
Table 34: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......36
Table 35: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......37
Table 36: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......38
Table 37: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......39
Table 38: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......40
Table 39: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......41
Table 40: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......42
Table 41: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......43
Table 42: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......44
Table 43: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......45
Table 44: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......46
Table 45: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......47
Table 46: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......48
Table 47: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......49
Table 48: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......50
Cervical Cancer......51
Table 49: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......51
Table 50: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......52
Hematological Cancer......53
Table 51: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......53
Skin Cancer......54
Table 52: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......54
Cancer-Associated Mucositis......55
Table 53: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......55
Chronic Myelogenous Leukemia (CML)......56
Table 54: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......56
Multiple Myeloma......57
Table 55: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......57
Table 56: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......58
Nausea and Vomiting Associated With Cancer Chemotherapy......59
Table 57: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......59
Ophthalmic Drugs......60
Table 58: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......60
Table 59: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......61
Erythropoietin (EPO)......62
Table 60: Biosimilars Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......62
Table 61: Proteins Market by Segment in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibody (MAb), Nerve Growth Factor (NGF), and Somatropin......63
Table 62: Therapeutic Biologics Market by Type in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......64
Vascular Endothelial Growth Factor......65
Table 63: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......65
Table 64: Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Avastin, Eylea, and Lucentis......66
Dialysis......67
Table 65: Market Shares of Leading Dialysis Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc. and Others......67
Hemodialysis Products......68
Table 66: Market Shares of Leading Hemodialysis Products Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Baxter International, Inc., Fresenius SE & Co. KGaA (FMC), and Others......68
Peritoneal Dialysis Products......69
Table 67: Market Shares of Leading Peritoneal Dialysis Products Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Baxter International, Inc., Fresenius SE & Co. KGaA (FMC), and Others......69
Dialysis Service......70
Table 68: Market Shares of Leading Dialysis Clinic Service Providers in the US (2015) - Percentage Breakdown by Value for American Renal Associates, Inc., DaVita Healthcare Partners, Inc., Dialysis Clinic, Inc., Fresenius SE & Co. KGaA, U.S. Renal Care-DSI Renal, Inc., and Others......70
Table 69: Market Shares of Leading Dialysis Service Providers by Value Sales in the US (2014) - Percentage Breakdown for DaVita Healthcare Partners, Inc., Fresenius SE & Co. KGaA, and Others......71
Cancer Drugs......72
Table 70: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......72
Table 71: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......73
Table 72: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......74
Table 73: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......75
Table 74: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......76
Breast Cancer Drugs......77
Table 75: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......77
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......78
Table 76: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......78
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......79
Table 77: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......79
Table 78: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......80
Ophthalmology Drugs......81
Table 79: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......81
Table 80: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......82
Erythropoietin (EPO)......83
Table 81: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co., Ltd., and Others......83
Recombinant Human Erythropoietin (RhEpo)......84
Table 82: Market Shares of Leading Recombinant Human Erythropoietin (RhEpo) Manufacturers in China (2015) - Percentage Share Breakdown by Value for 3s Bio Inc., Harbin Pharmaceutical Group Co., Ltd., Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd., Sihuan Pharmaceutical Holdings Group Ltd and Others......84